SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001104659-21-007168
Filing Date
2021-01-25
Accepted
2021-01-25 16:16:38
Documents
98

Document Format Files

Seq Description Document Type Size
1 F-1 tm2036979-2_f1.htm F-1 5335427
2 EXHIBIT 1.1 tm2036979d3_ex1-1.htm EX-1.1 217414
3 EXHIBIT 3.4 tm2036979d3_ex3-4.htm EX-3.4 25183
4 EXHIBIT 5.1 tm2036979d3_ex5-1.htm EX-5.1 48528
5 EXHIBIT 8.1 tm2036979d3_ex8-1.htm EX-8.1 20995
6 EXHIBIT 8.2 tm2036979d3_ex8-2.htm EX-8.2 19736
7 EXHIBIT 8.3 tm2036979d3_ex8-3.htm EX-8.3 6628
8 EX-10.42 tm2036979d3_ex10-42.htm EX-10.42 21991
9 EX-10.43 tm2036979d3_ex10-43.htm EX-10.43 16759
10 EXHIBIT 10.44 tm2036979d3_ex10-44.htm EX-10.44 32250
11 EXHIBIT 10.46 tm2036979d3_ex10-46.htm EX-10.46 19500
12 EXHIBIT 10.47 tm2036979d3_ex10-47.htm EX-10.47 72284
13 EXHIBIT 10.48 tm2036979d3_ex10-48.htm EX-10.48 43145
14 EXHIBIT 23.1 tm2036979d3_ex23-1.htm EX-23.1 2150
15 GRAPHIC lg_curevac-4c.jpg GRAPHIC 41107
16 GRAPHIC tm2036979d1-bc_activ4clr.jpg GRAPHIC 83682
17 GRAPHIC tm2036979d1-bc_dose4clr.jpg GRAPHIC 237079
18 GRAPHIC tm2036979d1-bc_higher4clr.jpg GRAPHIC 55405
19 GRAPHIC tm2036979d1-bc_impac4clr.jpg GRAPHIC 158486
20 GRAPHIC tm2036979d1-bc_lvl4clr.jpg GRAPHIC 51034
21 GRAPHIC tm2036979d1-bc_mice4clr.jpg GRAPHIC 119710
22 GRAPHIC tm2036979d1-bc_mild4clr.jpg GRAPHIC 120001
23 GRAPHIC tm2036979d1-bc_mn4clr.jpg GRAPHIC 1973537
24 GRAPHIC tm2036979d1-bc_mrna4clr.jpg GRAPHIC 49377
25 GRAPHIC tm2036979d1-bc_optimi4clr.jpg GRAPHIC 211681
26 GRAPHIC tm2036979d1-bc_orf4clr.jpg GRAPHIC 55752
27 GRAPHIC tm2036979d1-bc_perli4clr.jpg GRAPHIC 148385
28 GRAPHIC tm2036979d1-bc_protein4clr.jpg GRAPHIC 70518
29 GRAPHIC tm2036979d1-bc_rdb4clr.jpg GRAPHIC 111129
30 GRAPHIC tm2036979d1-bc_sars4clr.jpg GRAPHIC 140220
31 GRAPHIC tm2036979d1-bc_serum4clr.jpg GRAPHIC 151837
32 GRAPHIC tm2036979d1-bc_spik4clr.jpg GRAPHIC 152792
33 GRAPHIC tm2036979d1-bc_viral4clr.jpg GRAPHIC 120555
34 GRAPHIC tm2036979d1-bc_vnt4clr.jpg GRAPHIC 72399
35 GRAPHIC tm2036979d1-fc_cv7bwlr.jpg GRAPHIC 74602
36 GRAPHIC tm2036979d1-lc_absco4clr.jpg GRAPHIC 82426
37 GRAPHIC tm2036979d1-lc_amin4clr.jpg GRAPHIC 107032
38 GRAPHIC tm2036979d1-lc_area4clr.jpg GRAPHIC 60787
39 GRAPHIC tm2036979d1-lc_boos4clr.jpg GRAPHIC 2051098
40 GRAPHIC tm2036979d1-lc_cone4clr.jpg GRAPHIC 84630
41 GRAPHIC tm2036979d1-lc_cv7024clr.jpg GRAPHIC 122178
42 GRAPHIC tm2036979d1-lc_cv7204clr.jpg GRAPHIC 88530
43 GRAPHIC tm2036979d1-lc_design4clr.jpg GRAPHIC 114631
44 GRAPHIC tm2036979d1-lc_exten4clr.jpg GRAPHIC 62566
45 GRAPHIC tm2036979d1-lc_growth4clr.jpg GRAPHIC 64603
46 GRAPHIC tm2036979d1-lc_improv4clr.jpg GRAPHIC 59051
47 GRAPHIC tm2036979d1-lc_live4clr.jpg GRAPHIC 128637
48 GRAPHIC tm2036979d1-lc_lnp4clr.jpg GRAPHIC 93924
49 GRAPHIC tm2036979d1-lc_surv4clr.jpg GRAPHIC 64624
50 GRAPHIC tm2036979d1-lc_surviv4clr.jpg GRAPHIC 102481
51 GRAPHIC tm2036979d1-lc_total4clr.jpg GRAPHIC 59345
52 GRAPHIC tm2036979d1-lc_tumor4clr.jpg GRAPHIC 86892
53 GRAPHIC tm2036979d1-pht_bio4clr.jpg GRAPHIC 65084
54 GRAPHIC tm2036979d1-pht_body4clr.jpg GRAPHIC 172298
55 GRAPHIC tm2036979d1-pht_chara4clr.jpg GRAPHIC 282414
56 GRAPHIC tm2036979d1-pht_class4clr.jpg GRAPHIC 90676
57 GRAPHIC tm2036979d1-pht_cold4clr.jpg GRAPHIC 316685
58 GRAPHIC tm2036979d1-pht_combain4clr.jpg GRAPHIC 78138
59 GRAPHIC tm2036979d1-pht_cvcm4clr.jpg GRAPHIC 125397
60 GRAPHIC tm2036979d1-pht_design4clr.jpg GRAPHIC 126388
61 GRAPHIC tm2036979d1-pht_divers4clr.jpg GRAPHIC 203003
62 GRAPHIC tm2036979d1-pht_formula4clr.jpg GRAPHIC 227251
63 GRAPHIC tm2036979d1-pht_gmb4clr.jpg GRAPHIC 154195
64 GRAPHIC tm2036979d1-pht_mela4clr.jpg GRAPHIC 150150
65 GRAPHIC tm2036979d1-pht_metas4clr.jpg GRAPHIC 152863
66 GRAPHIC tm2036979d1-pht_muscle4clr.jpg GRAPHIC 332872
67 GRAPHIC tm2036979d1-pht_number4clr.jpg GRAPHIC 138931
68 GRAPHIC tm2036979d1-pht_option4clr.jpg GRAPHIC 173617
69 GRAPHIC tm2036979d1-pht_perfer4clr.jpg GRAPHIC 391383
70 GRAPHIC tm2036979d1-pht_pertre4clr.jpg GRAPHIC 93746
71 GRAPHIC tm2036979d1-pht_recis4clr.jpg GRAPHIC 213747
72 GRAPHIC tm2036979d1-pht_rna4clr.jpg GRAPHIC 122702
73 GRAPHIC tm2036979d1-pht_role4clr.jpg GRAPHIC 196459
74 GRAPHIC tm2036979d1-pht_sub4clr.jpg GRAPHIC 101047
75 GRAPHIC tm2036979d1-pht_transis4clr.jpg GRAPHIC 246006
76 GRAPHIC tm2036979d1-pht_treat4clr.jpg GRAPHIC 138741
77 GRAPHIC tm2036979d1-pht_unmodiclr.jpg GRAPHIC 135515
78 GRAPHIC tm2036979d1-pht_vaccin4clr.jpg GRAPHIC 82908
79 GRAPHIC tm2036979d2-bc_vnt4clr.jpg GRAPHIC 117473
80 GRAPHIC tm2036979d2-lc_mrnavac14clr.jpg GRAPHIC 161352
81 GRAPHIC tm2036979d2-lc_mrnavac4clr.jpg GRAPHIC 220328
82 GRAPHIC tm2036979d2-lc_sars14clr.jpg GRAPHIC 104781
83 GRAPHIC tm2036979d2-lc_sars24clr.jpg GRAPHIC 106243
84 GRAPHIC tm2036979d2-lc_sars34clr.jpg GRAPHIC 106848
85 GRAPHIC tm2036979d2-pht_ident4clr.jpg GRAPHIC 162405
86 GRAPHIC tm2036979d2-pht_immune4c.jpg GRAPHIC 154562
87 GRAPHIC tm2036979d2-pht_product4c.jpg GRAPHIC 1751962
88 GRAPHIC tm2036979d3_10-43img01.jpg GRAPHIC 10171
89 GRAPHIC tm2036979d3_10-43img02.jpg GRAPHIC 106870
90 GRAPHIC tm2036979d3_10-43img03.jpg GRAPHIC 120900
91 GRAPHIC tm2036979d3_ex10-48img001.jpg GRAPHIC 2590
92 GRAPHIC tm2036979d3_ex8-1img001.jpg GRAPHIC 7912
93 GRAPHIC tm2036979d3_ex8-2img001.jpg GRAPHIC 2749
94 GRAPHIC tm2036979d3_ex8-2img002.jpg GRAPHIC 3881
95 GRAPHIC tm2036979d3_ex8-2img003.jpg GRAPHIC 1760
96 GRAPHIC tm2036979d3_ex5-1img01.jpg GRAPHIC 5042
97 GRAPHIC tm2036979d3_ex8-1img002.jpg GRAPHIC 5335
98 GRAPHIC tm2036979d3_ex3-4img001.jpg GRAPHIC 2844
  Complete submission text file 0001104659-21-007168.txt   26762206
Mailing Address PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076
Business Address PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076 49 7071 9883 0
CureVac N.V. (Filer) CIK: 0001809122 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-252391 | Film No.: 21549818
SIC: 2834 Pharmaceutical Preparations